Following the current study by TCSBN correlation analysis of SERTAD1 in cancer and normal tissue, SERTAD1 significantly correlated with JOSD2 (Corr = 6.15) and UBE2S (Corr = 0.588) in breast tumor and normal tissue respectively (Figure 6C and Table S3). Here, JOSD2 is linked to cancer.